Balance Labs

🇨🇳 China A-share · Pharma · Updated

600196.SS dividend FAQ — coverage before yield

By the Balance Labs Research Desk · Reviewed by the editorial review board ·

Fosun Pharma (600196.SS) dividend questions, answered with the dated workflow — snapshot 2026-08-29: ¥22.84 · signal LONG. No predictions, no hype.

Key facts — quick answer

Does 600196.SS pay a dividend?

Dividend treatment depends on the listing (China A-share); the discipline is universal — coverage and durability before headline yield. The dated brief inside the app assembles Fosun Pharma's numbers directly.

Is the 600196.SS dividend safe?

Check payout ratio, FCF coverage, debt trajectory, and dividend-growth history — in that order. A yield that looks too good usually prices a cut.

How is 600196.SS for income investors?

Fosun Pharma is a Pharma business first; income fit depends on whether its cash flows hold through the cycle. Run the workflow before the yield.

What is 600196.SS's dividend history?

The dividend research page and the live brief show the dated series — history is context, coverage is the test.

Where is the full 600196.SS dividend research?

The dividend page link is below; the app's dividend view updates with each close.

Run the live 600196.SS dividend — free

Stock Chat + Screener preview · 30 monthly AI credits.

Open 600196.SS in Balance Labs

Get more Balance Labs in your Google results

Add balancelabs.app as a Preferred Source on Google.

← FAQ hub · All guides · Data snapshot 2026-08-29 · Not investment advice.